ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 61 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,551 | -38.2% | 7,035 | -44.5% | 0.00% | – |
| Q2 2023 | $130,361 | +284.5% | 12,681 | +188.7% | 0.00% | – |
| Q1 2023 | $33,906 | +3290.6% | 4,392 | +3358.3% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 127 | -56.2% | 0.00% | – |
| Q2 2022 | $2,000 | -96.1% | 290 | -94.9% | 0.00% | – |
| Q1 2022 | $51,000 | -60.8% | 5,703 | -39.6% | 0.00% | – |
| Q4 2021 | $130,000 | -77.8% | 9,438 | -82.8% | 0.00% | – |
| Q3 2021 | $585,000 | +19400.0% | 54,878 | +18192.7% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 300 | -18.0% | 0.00% | – |
| Q1 2021 | $4,000 | +300.0% | 366 | +446.3% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 67 | +6.3% | 0.00% | – |
| Q3 2020 | $1,000 | – | 63 | +142.3% | 0.00% | – |
| Q2 2020 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 26 | -93.5% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -96.6% | 400 | -96.4% | 0.00% | – |
| Q1 2018 | $88,000 | -25.4% | 10,993 | +4.0% | 0.00% | – |
| Q4 2017 | $118,000 | – | 10,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |